Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
Clinical trial NCT02180217 · COMPLETED
Trial details
- NCT number
- NCT02180217
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-06
- Primary completion
- 2018-02-21
- Enrollment
- 137
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.